QNL

Medium-Term Adjunctive Predictive Cardiovascular Indicator

Product code
QNL
Device name
Medium-Term Adjunctive Predictive Cardiovascular Indicator
Device class
Class 2
21 CFR
21 CFR 870.2210
Medical specialty
Cardiovascular
Marketing pathway
510(K)
510(k) clearances (last 3 years)
3
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
5 (all years; only the last 3 years are listed here)

FDA classification definition

The adjunctive predictive cardiovascular indicator is a prescription device that uses software algorithms to analyze cardiovascular vital signs and predict future cardiovascular status or events within a defined medium-term period. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (3)

Last three years. Most recent: 2024-06-21.

NumberDecision dateApplicantDevice nameSummary
K2332532024-06-21Agilemd, Inc.eCARTv5 Clinical Deterioration Suite (“eCART”)PDF
K2332162024-01-13Clew Medical , Ltd.CLEWICU SystemPDF
K2308422023-10-25Implicity, Inc.SignalHF (IM008)PDF

3 summaries are archived here for direct download.

Official FDA classification page: QNL
Classification and pathway per current FDA publications. Data from openFDA (CC0).